openPR Logo
Press release

Ankylosing Spondylitis Treatment Market is expected to reach USD 8.3 billion by 2034

11-13-2025 08:30 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Ankylosing Spondylitis Treatment

Ankylosing Spondylitis Treatment

The Ankylosing Spondylitis Treatment Market was valued at USD 5.2 billion in 2024 and is expected to reach USD 8.3 billion by 2034, growing at a CAGR of 4.7% during the forecast period. North America leads the global market with around 45% share, driven by high diagnosis rates and access to advanced biologics, while Asia-Pacific is the fastest-growing region, expected to expand at nearly 8% CAGR due to rising patient awareness, improving healthcare infrastructure, and increased adoption of innovative therapies.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50081

Market Segmentation Highlights
By Drug Type
• NSAIDs dominate (~40% share).
• Biologics (IL-17 inhibitors, JAK inhibitors) are the fastest-growing segment.

By Route of Administration
• Oral administration leads (~50% share).
• Injectable & intravenous routes growing due to biologics.

By Therapeutic Area
• Pain management accounts for ~60% of the market.
• Anti-inflammatory treatment segment expanding rapidly.

By End-User
• Hospitals dominate.
• Clinics and home-care settings increasing steadily.

By Region
• North America: ~45% share.
• Europe: ~30% share; ~5% CAGR.
• Asia-Pacific: ~15% share but fastest growth (~8% CAGR).
• Latin America & Middle East/Africa: Emerging opportunity regions.

Explore Full Report here: https://exactitudeconsultancy.com/reports/50081/ankylosing-spondylitis-treatment-market

Growth Drivers, Challenges & Opportunities
Drivers
• Rising prevalence of Ankylosing Spondylitis.
• Advancements in biologic and targeted therapies.
• Growth of affordable biosimilars.

Challenges
• High cost of biologics and targeted therapies.
• Limited treatment access in developing regions.
• Regulatory approval delays and supply-chain constraints.

Opportunities
• Expansion of tele-medicine and home-based treatment models.
• Personalized medicine and next-gen treatment modalities.
• Rapid healthcare development in APAC & Latin America.

Strategic Implications for Companies
• Focus on next-generation biologics and targeted IL-17/JAK therapies.
• Leverage biosimilar production to improve affordability.
• Expand operations in high-growth APAC markets.
• Strengthen patient-centric solutions, including self-injectable options.
• Address reimbursement and access challenges to increase adoption.

This report is also available in the following languages : Japanese (強直性脊椎炎治療市場), Korean (강직성 척추염 치료 시장), Chinese (强直性脊柱炎治疗市场), French (Marché des traitements contre la spondylarthrite ankylosante), German (Markt für die Behandlung von Morbus Bechterew), and Italian (Mercato del trattamento della spondilite anchilosante), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50081/ankylosing-spondylitis-treatment-market#request-a-sample

Our More Reports:

Ankylosing Spondylitis Medication Market
https://exactitudeconsultancy.com/reports/65992/ankylosing-spondylitis-medication-market

Golimumab (Simponi) Market
https://exactitudeconsultancy.com/reports/66417/golimumab-simponi-market

Ankylosing Spondylitis Market
https://exactitudeconsultancy.com/reports/70982/ankylosing-spondylitis-market

Ankylosing spondylitis Patient Pool Market
https://exactitudeconsultancy.com/reports/71014/ankylosing-spondylitis-patient-pool-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Treatment Market is expected to reach USD 8.3 billion by 2034 here

News-ID: 4268337 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Market Treatment Advances and Global Growth Forecast
The Ankylosing Spondylitis (AS) Market focuses on therapies, diagnostics, and devices used for managing ankylosing spondylitis, a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. AS is characterized by pain, stiffness, and progressive spinal fusion, which can significantly impact patient quality of life. Market offerings include biologic therapies, non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), physiotherapy tools, and diagnostic imaging solutions. Download Full PDF Sample Copy of Market
Ankylosing Spondylitis Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ankylosing Spondylitis Market Size By 2025? The valuation of the ankylosing spondylitis sector has experienced robust expansion over the past few years, projected to advance from a figure of $5.9 billion in the year 2024 up to $6.34 billion by 2025, reflecting a compound annual
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate? The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638 Introduction: The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively. Unveiling Ankylosing
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen